ERBB2 and cancer: With the identification of cancer antigens in basic researches in recent years, several cancer-specific peptides, such as MUC-1, MART-1, TRP-2, gp100, NYESO, Her2/neu, and others, had been administered to cancer patients with an adjuvant, with or without dendritic cells.